Dec. 30 (UPI) -- The Food and Drug Administration is expected to approve Pfizer-BioNTech's COVID-19 booster shots for 12-to-15-year-olds next week, unnamed sources familiar with the decision said Thursday.
The sources told The New York Times, The Washington Post and CNN that the booster will be recommended five months after the older children receive their second vaccine, instead of the six months currently advised for adults.